Identification of Licopyranocoumarin and Glycyrurol from Herbal Medicines as Neuroprotective Compounds for Parkinson's Disease

Abstract

<div><p>In the course of screening for the anti-Parkinsonian drugs from a library of traditional herbal medicines, we found that the extracts of <i>choi-joki-to</i> and <i>daio-kanzo-to</i> protected cells from MPP<sup>+</sup>-induced cell death. Because <i>choi-joki-to</i> and <i>daio-kanzo-to</i> commonly contain the genus <i>Glycyrrhiza</i>, we isolated licopyranocoumarin (LPC) and glycyrurol (GCR) as potent neuroprotective principals from <i>Glycyrrhiza</i>. LPC and GCR markedly blocked MPP<sup>+</sup>-induced neuronal PC12D cell death and disappearance of mitochondrial membrane potential, which were mediated by JNK. LPC and GCR inhibited MPP<sup>+</sup>-induced JNK activation through the suppression of reactive oxygen species (ROS) generation, thereby inhibiting MPP<sup>+</sup>-induced neuronal PC12D cell death. These results indicated that LPC and GCR derived from <i>choi-joki-to</i> and <i>daio-kanzo-to</i> would be promising drug leads for PD treatment in the future.</p></div

Similar works

Full text

thumbnail-image

The Francis Crick Institute

redirect
Last time updated on 12/02/2018

This paper was published in The Francis Crick Institute.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.